Improving modes of delivery, deployment, and uptake of vaccines through phase IV/implementation research
The 'Improving modes of delivery, deployment, and uptake of vaccines through phase IV/implementation research' program is a pivotal initiative under the Horizon Europe framework, specifically designed to address critical public health challenges in sub-Saharan Africa. By focusing on advanced vaccine delivery solutions and understanding behavioral barriers to vaccine uptake, it distinguishes itself through a strong emphasis on implementation research and direct impact on vulnerable communities. The program's core objective is to enhance global health outcomes by translating research findings into tangible policy guidelines and improving vaccine accessibility.
Who is Funded: Eligibility and Objectives
This section outlines the eligibility criteria for organizations and individuals seeking funding, specifying the required geographic presence and the overarching objectives that projects must align with. The program prioritizes collaborative research efforts, particularly those involving entities from sub-Saharan Africa, to maximize its impact on vaccine delivery and public health.
What is Funded: Research Areas and Project Stages
This section details the types of projects and thematic areas eligible for funding, focusing on vaccine deployment and uptake through advanced research and innovative solutions. It also highlights the specific developmental stage of projects supported, emphasizing implementation and real-world impact.
Type and Scope of Funding
This section provides information on the type of financial support available and the maximum funding amount per project. The program offers grants as its primary financial instrument, supporting impactful research efforts.
Conditions and Requirements
This section outlines the key rules and specific conditions that applicants and beneficiaries must adhere to, covering aspects from general eligibility to specific exploitation obligations and intellectual property rights. Compliance with these provisions is crucial for successful participation.
Application Procedure
The application process for this program follows a two-stage submission and evaluation procedure, with detailed criteria for assessing proposals. Successful applicants are selected based on their adherence to strict thresholds in excellence, impact, and implementation quality, ensuring a rigorous and transparent selection of projects.
Legal Basis
This section outlines the fundamental legal and official documents that govern the 'Improving modes of delivery, deployment, and uptake of vaccines through phase IV/implementation research' funding program. These legal bases ensure the program's legitimacy and provide the regulatory framework for its operation and financial management.
Similar Programs
Funding Overview
Funding Status:
Closed
Maximum Amount:
5.000.000 €
Allocated Budget:
30.000.000 EUR
Award Channel:
Framework Programme Call
Region:
European Union Member States, Overseas Countries and Territories, Horizon Europe Associated Countries, and specific sub-Saharan African countries that are members of the EDCTP Association (including Burkina Faso, Cameroon, Congo, Côte d’Ivoire, Democratic Republic of the Congo, Ethiopia, Gabon, The Gambia, Ghana, Guinea, Kenya, Liberia, Malawi, Mali, Mozambique, Niger, Nigeria, Rwanda, Senegal, South Africa, Tanzania, Uganda, Zambia, Zimbabwe).
Sectors:
Healthcare, Research and Development, Pharmaceutical Industry, Social Enterprises, Other
Beneficiaries:
Public health authorities, health care professionals, people in sub-Saharan Africa, vulnerable groups, communities
Application Type:
Consortium Required
Funding Stages:
Applied Research, Implementation, Policy Development, Service Delivery
Funding Provider
Program Level:
European Union
Funding Body:
Global Health EDCTP3 Joint Undertaking
Managed By:
Global Health EDCTP3 Joint Undertaking
Additional Partners:
The program encourages research consortia with strong representation from African countries, including Franco/Lusophone countries. Collaboration with policy makers, public health authorities, health care professionals, and end-users is expected. Strong community engagement is also required. Networking and joint activities among funded projects are encouraged.
Website: